Object Pharma Announces Strategic Acquisition of Metabiologics

NEWPORT BEACH, Calif. (PRWEB) May 30, 2019 Object Pharma, Inc., a startup company innovating the future of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production and sale of botulinum neurotoxins for research. The a…

Source link

Related posts

garbagevalue:Props for correcting misinformation. General FYI this is a pretty good article…


Should I stay or should I go? The settlement-inducing protein complex guides barnacle settlement decisions [RESEARCH ARTICLE]


Stochastic Variational Inference for Bayesian Phylogenetics: A Case of CAT Model


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy